Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
about
Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1Development of dengue virus replicons expressing HIV-1 gp120 and other heterologous genes: a potential future tool for dual vaccination against dengue virus and HIVHIV-1 prophylactic vaccines: state of the artLive attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaquesCharacterization of CD8+ T cell differentiation following SIVΔnef vaccination by transcription factor expression profilingRectal HSV-2 Infection May Increase Rectal SIV Acquisition Even in the Context of SIVΔnef VaccinationCD8 T cell response maturation defined by anentropic specificity and repertoire depth correlates with SIVΔnef-induced protectionLong-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccineADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challengeTetraspanins in viral infections: a fundamental role in viral biology?Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsThe HIV-1 Nef protein as a target for antiretroviral therapy.Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaquesIncorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity.Why primate models matter.Human immunodeficiency virus vaccine trialsAllogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaquesAcute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure.Molecularly cloned SHIV-1157ipd3N4: a highly replication- competent, mucosally transmissible R5 simian-human immunodeficiency virus encoding HIV clade C Env.Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1Multi-low-dose mucosal simian immunodeficiency virus SIVmac239 challenge of cynomolgus macaques immunized with "hyperattenuated" SIV constructs.Factors associated with slow disease progression in macaques immunized with an adenovirus-simian immunodeficiency virus (SIV) envelope priming-gp120 boosting regimen and challenged vaginally with SIVmac251.Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.Recombinant vaccine-induced protection against the highly pathogenic simian immunodeficiency virus SIV(mac251): dependence on route of challenge exposure.Epithelial uptake and transport of cell-free human immunodeficiency virus type 1 and gp120-coated microparticlesDNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.Temporal analyses of virus replication, immune responses, and efficacy in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus.Pathogenic conversion of live attenuated simian immunodeficiency virus vaccines is associated with expression of truncated NefComparative efficacy of recombinant modified vaccinia virus Ankara expressing simian immunodeficiency virus (SIV) Gag-Pol and/or Env in macaques challenged with pathogenic SIVEvidence for recombination of live, attenuated immunodeficiency virus vaccine with challenge virus to a more virulent strain.Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boostPersistent infection of rhesus macaques by the rev-independent Nef(-) simian immunodeficiency virus SIVmac239: replication kinetics and genomic stabilityIn vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.Rabies virus-based vectors expressing human immunodeficiency virus type 1 (HIV-1) envelope protein induce a strong, cross-reactive cytotoxic T-lymphocyte response against envelope proteins from different HIV-1 isolates.Immunization of macaques with single-cycle simian immunodeficiency virus (SIV) stimulates diverse virus-specific immune responses and reduces viral loads after challenge with SIVmac239
P2860
Q24516944-D2CDD8B9-0CE9-41C8-BF53-AC752C22D461Q24797123-B914FE64-0BC4-4870-BCB9-1475FF76C408Q26740042-8ABF30E9-C62B-446D-B142-81BC1BBB156BQ27305234-0488DB3D-045A-4E9C-8F12-C2CD81C94662Q27320870-EE4C61E6-C98D-41C9-BC80-2D472B043363Q27321160-7CF6C378-2869-4F95-A443-07EF7CE6E66FQ27321448-F626FA48-6BDE-4736-8519-5421EFE5C1F0Q27334460-4403EC49-0401-4BAD-B0FE-0E855EA94C93Q27342615-72282E77-681D-455E-BDD7-10D3A3BF5216Q27470936-808C243F-9387-4530-ABF5-34ED902DBD78Q28345395-01E6B342-4AFA-49D2-BD1E-0C926D73217BQ28394899-36103F38-2A57-494E-8618-E2A1BDB173B7Q30160188-6B3EC339-E189-4F1F-87A8-A897EA6ECF05Q30176158-2D2694F7-5A44-4FA4-87CF-A3A65ABABE90Q30373512-7212CDC3-8188-4426-888F-86C06B7EB8BBQ30417520-2382AC7F-FC83-4676-BFE0-FC1CBFBBE3D1Q30424366-2A0E00C3-D4A1-454D-922B-35AE49097556Q33342850-93431EC8-F046-475A-8A79-DE957C61F3BCQ33354076-12BAE68D-031E-4063-A904-BC8D22CD44B0Q33372270-B2FCE590-3492-4023-ACAD-B69CF6A40DA2Q33402455-B531EF3E-A2E8-4F08-835A-75E2D1C9F8A3Q33606773-31A06F80-DA69-46C4-BF42-4A98FBD56421Q33648905-2B1DF584-3ACA-4267-BF4C-68BAF9A7B2ACQ33649657-B49D5CBA-65F6-4A08-87B3-819CB95B55CFQ33717525-6153E106-802A-40C1-ABF3-4A09796D8B25Q33782797-4FD44BB7-C223-49E4-A14E-357135B07866Q33782821-1BD5A65A-E633-472A-9765-87AF24F169FEQ33783841-350E77A1-034C-4090-B294-994F6539FEB2Q33783960-EB22AB1D-87DD-4508-89A9-2377A3BFD44AQ33786257-205C44AA-47E6-4B61-A0C6-27714BCC1C7FQ33798199-231521BA-E37F-4BC2-A022-D4AECB167FE3Q33800033-CC05D223-E789-45C8-8061-383BD572C4B8Q33802066-445F4493-E299-436B-BA09-FD6B7CE5788AQ33803217-E771DA21-A828-41F7-810C-B5B822BB408CQ33806370-D79B6C5E-8BCC-4A53-91C8-A09F19480F4AQ33813173-D1F1E6D3-4A81-4BA5-A8DF-F383EB46D0E8Q33816133-5A71C2B8-6623-4A49-87FF-87FA804A8EE4Q33834814-B5CBC774-F22F-4C91-AEA1-E857F10AEDC4Q33839981-9692938B-E2DE-4D63-876E-DA6E7BA3EC62Q33843131-8D469A28-D5BD-4130-8899-4FF1A90D92B3
P2860
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@ast
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@en
type
label
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@ast
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@en
prefLabel
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@ast
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@en
P2093
P356
P1433
P1476
Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques.
@en
P2093
P304
P356
10.1126/SCIENCE.7892606
P407
P577
1995-03-01T00:00:00Z